icer white paper affordable access to glp-1 obesity medications 2025 says GLP-1s 'still have serious affordability issues' How Supply and Demand for

Note: these products cant be marketed as semaglutide but as containing the same active ingredients

This distinction is critical, as even a biologically promising compound may become clinically harmful when delivered through nonstandardized formulations

difficile infection (watery diarrhea three or more times daily, fever, abdominal cramps, or diarrhea persisting after antibiotics end)

62 RavanelS.JobD.DouceR

Medications and supplements We may recommend options such as: PDE-5 inhibitors Acetyl L-Carnitine L-Arginine Topical Diclofenac (1% Gel) These treatments aim to reduce inflammation, soften plaque, and improve comfort (Restorative Health Clinic, 2025)